Is Vitamin D Level Associated with COVID-19 Infection?

Year 2022, Volume: 6 Issue: 1, 48 - 52, 28.04.2022

Fatih Okan , Sevil Okan , Yasemin Hanoğlu

https://doi.org/10.29058/mjwbs.1059760

Cited By: 1

Abstract

Aim: The effects of vitamin D, which has an antiviral and immune modulator in preventing the rapidly
spreading COVID-19, which has been resulting in increasing number of deaths worldwide, is discussed.
The aim of the present study was to determine whether 25-hydroxyvitamin D level is associated with
COVID-19 risk.
Material and Methods: Ninety-six individuals (48 COVID-19 positive and 48 COVID-19 negative) were
included in this cross-sectional study. Data were collected with a questionnaire form evaluating the
individual and clinical characteristics of the study participants, their eating habits affecting vitamin D
status and their sun exposures. 25-hydroxyvitamin D measurements and polymerase chain reaction
test results were evaluated. Independent samples t test was used to compare the age, BFUI and vitamin
D levels of the patient and control groups while Chi-square and Fisher’s exact test were used for the
ratio comparisons of categorical variables.
Results: It was found that 86.5% of the study participants had vitamin D deficiency. There was no
significant difference between 25-hydroxyvitamin D levels of individuals who tested positive for COVID-19
and those who did not (11.50 ± 6.66 ng/ml and 12.95 ± 6.11 ng/ml, respectively, p = 0.271). Vitamin
D status (severely deficient, deficient, insufficient) was similar in those with and without COVID-19
infection (p = 0.586).
Conclusion: Our findings do not support the potential link between COVID-19 infection risk and
25-hydroxyvitamin D level or vitamin D status.

Keywords

25(OH)D, COVID-19, Infection, Sunlight, Vitamin D status

D Vitamini Düzeyi COVID-19 Enfeksiyonu ile İlişkili midir?

Abstract

Amaç: Antiviral ve immün modülatör etkisi olan D vitamininin, dünya çapındaki artan ölüm sayısıyla
birlikte hızla yayılan COVID-19’u önlemedeki etkisi tartışılmaktadır. Çalışmanın amacı 25-hidroksivitamin
D düzeyinin COVID-19 riski ile ilişkili olup olmadığının belirlenmesidir.
Gereç ve Yöntemler: Kesitsel tipteki çalışmaya 96 birey (48 COVID-19 pozitif ve 48 COVID-19 negatif)
dahil edildi. Çalışmaya katılanların bireysel ve klinik özelliklerini, D vitamini durumlarını etkileyen
beslenme alışkanlıklarını ve güneş maruziyetlerini değerlendiren anket formu ile veriler toplandı.
25-hidroksivitamin D düzeyi ölçümleri ve Polimeraz Zincir Reaksiyonu test sonuçları değerlendirildi.
Bulgular: Çalışmaya katılanların %86,5’inde D vitamini eksikliği olduğu bulundu. Çalışmada COVID-19
testi pozitif olan ve olmayan bireylerin 25-hidroksivitamin D düzeyi ortalamaları arasında istatistiksel
olarak anlamlı fark bulunmadı (sırasıyla 11,50 ± 6,66 ng/ml, 12,95 ± 6,11 ng/ ml, p = 0,271). D vitamini
durumu (ciddi eksiklik, eksiklik, yetersizlik) COVID -19 enfeksiyonu olan ve olmayanlar arasında benzer
bulundu (p = 0,586). Hasta ve kontrol gruplarının yaşı, BFUI ve D vitamini düzeylerinin karşılanmasında
iki ortalama arasındaki farkın önemlilik testi; kategorik değişkenlerin oran karşılaştırmaları için Ki-kare
ve Fisher’in kesin testi kullanıldı.
Sonuç: Bulgularımız 25- hidroksivitamin D düzeyi ve D vitamini durumu ile COVID-19 enfeksiyonu riski
arasında potansiyel bağlantıyı desteklememektedir.

Keywords

25(OH) D, COVID-19, D vitamini durumu, Enfeksiyon, Güneş ışığı

References

• 1. Ferrari D, et al. Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?. Cell Biochem Funct. 2021; 39(1): 35-47.
• 2. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) https://coronavirus.jhu.edu/ map.html. Accessed November 1, 2021.
• 3. Laird E, et al . Vitamin D and Inflammation: Potential Implications for Severity of Covid-19. Ir Med J. 2020; 113(5): 81.
• 4. Holick MF, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Jul; 96(7): 1911-30.
• 5- Grant WB, Boucher BJ. Randomized controlled trials of vitamin D and cancer incidence: a modeling study. PLoS One 2017; 12(5): e0176448.
• 6. Grant WB, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020 Apr 2; 12(4): 988.
• 7.Watkins J. Preventing a covid-19 pandemic. BMJ. 2020 Feb 28; 368: m810.
• 8. Ilie PC, et al. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 2020; 32(7): 1195-1198.
• 9. Hastie CE, et al. Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020 Jul-Aug; 14(4): 561-565.
• 10. Atli T, et al. The prevalence of Vitamin D deficiency and effects of ultraviolet light on Vitamin D levels in elderly Turkish population. Arch Gerontol Geriatr. 2005; 40(1): 53–60.
• 11. http://temd.org.tr. Osteoporoz ve Metabolik Kemik Hastalıkları Tanı ve Tedavi Kılavuzu. METABOLIK_KH_BOOK_web_.pdf. [cited May 1, 2021] Available from: http://temd.org.tr.
• 12. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol.2014; 144: 138–145.
• 13. Chodick G, et al. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection. J Travel Med 2020; 27(5): taaa069.
• 14. Merzon E, et al. Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020;287(17):3693-3702.
• 15. Mardani R, et al. Association of vitamin D with the modulation of the disease severity in COVID-19. Virus Res. 2020; 289: 198148.
• 16. Okan F, et al. Effect of Sunlight Exposure on Vitamin D Status of Individuals Living in a Nursing Home and Their Own Homes. J Clin Densitom 2020 ;23(1): 21-28.
• 17. Livingstone KM, et al. Weekday sunlight exposure, but not vitamin D intake, influences the association between vitamin D receptor genotype and circulating concentration 25-hydroxyvitamin D in apan-European population: the Food4Me study. Mol Nutr Food Res 2017; 61(2): 1600476.
• 18. D'Avolio A, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients 2020; 12(5): 1359.
• 19. Abdollahi A, et al. The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: A case-control study of hospitalized patients in Tehran, Iran. J Med Virol 2021; 93(4): 2359-2364.
• 20. Luo X, et al . Vitamin D Deficiency Is Associated with COVID-19 Incidence and Disease Severity in Chinese People J Nutr. 2021; 151(1): 98-103.
• 21. Bassatne A, et al. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis. Metabolism 2021; 119: 154753.
• 22. Demir M, et al. Vitamin D deficiency is associated with COVID-19 positivity and severity of the disease. J Med Virol. 2021;93(5):2992-2999. doi:10.1002/jmv.26832
• 23. Bayraktar N, et al. Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19. J Med Virol. 2022;94(1):154-160. doi:10.1002/jmv.27294
• 24. Berry DJ, et al. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 2011; 106(9): 1433-1440.
• 25. Kaufman HW, et al. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 2020; 15(9): e0239252.